AQR Arbitrage’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

AQR Arbitrage’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2M	Hold	1,324,175	–	–	0.2%	94
2026 Q1	$14.1M	Sell	1,324,175 -88,575	-6%	-$943K	0.23%	89
2025 Q4	$15M	Hold	1,412,750	–	–	0.32%	84
2025 Q3	$14.8M	Sell	1,412,750 -38,000	-3%	-$397K	0.38%	85
2025 Q2	$15.2M	Hold	1,450,750	–	–	0.35%	81
2025 Q1	$14.8M	Sell	1,450,750 -529,535	-27%	-$5.31M	0.35%	95
2024 Q4	$19.7M	Buy	+1,980,285	New	+$19.8M	0.43%	71

Other funds holding OACC

FBCM

Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

AQR Arbitrage's OACC Position: Q2 2026 in Review

AQR Arbitrage held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 1,324,175 shares worth $14.2M. The position accounts for 0.2% of the portfolio, ranked #94.

AQR Arbitrage first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. The position peaked at $19.7M in Q4 2024. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

AQR Arbitrage held 1,324,175 shares of Oaktree Acquisition Corp III Life Sciences worth $14.2M as of Q2 2026.
AQR Arbitrage left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
Oaktree Acquisition Corp III Life Sciences made up 0.2% of AQR Arbitrage's portfolio in Q2 2026, its #94 holding.
AQR Arbitrage first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
AQR Arbitrage's Oaktree Acquisition Corp III Life Sciences position peaked at $19.7M in Q4 2024.
51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.